A Study for the Treatment of Diabetic Peripheral Neuropathic Pain

NCT00552175 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

339

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathies

Interventions

DRUG: Duloxetine hydrochloride - 40 mg
DRUG: placebo
DRUG: Duloxetine hydrochloride - 60 mg

Sponsor

Eli Lilly and Company

Collaborators

[object Object]